Cargando…

Label-free enrichment of human blast cells from whole blood for leukemia monitoring

Liquid biopsy is an alternative to invasive bone marrow biopsy for leukemia detection and management. However, no robust technology is available for enriching leukemic blast cells from the blood. Here, we present a simple and effective protocol for vigorous enrichment of blast cells from whole blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yatian, Zou, Shangjie, Khoo, Bee Luan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307522/
https://www.ncbi.nlm.nih.gov/pubmed/35880120
http://dx.doi.org/10.1016/j.xpro.2022.101584
_version_ 1784752781490388992
author Fu, Yatian
Zou, Shangjie
Khoo, Bee Luan
author_facet Fu, Yatian
Zou, Shangjie
Khoo, Bee Luan
author_sort Fu, Yatian
collection PubMed
description Liquid biopsy is an alternative to invasive bone marrow biopsy for leukemia detection and management. However, no robust technology is available for enriching leukemic blast cells from the blood. Here, we present a simple and effective protocol for vigorous enrichment of blast cells from whole blood using a one-step microfluidic blast cell biochip (BCB) that exploits distinct cell mechanical properties between diseased and healthy leukocytes. The BCB system achieves higher sensitivity than flow cytometry in detecting blasts. For complete details on the use and execution of this protocol, please refer to Khoo et al. (2019).
format Online
Article
Text
id pubmed-9307522
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93075222022-07-24 Label-free enrichment of human blast cells from whole blood for leukemia monitoring Fu, Yatian Zou, Shangjie Khoo, Bee Luan STAR Protoc Protocol Liquid biopsy is an alternative to invasive bone marrow biopsy for leukemia detection and management. However, no robust technology is available for enriching leukemic blast cells from the blood. Here, we present a simple and effective protocol for vigorous enrichment of blast cells from whole blood using a one-step microfluidic blast cell biochip (BCB) that exploits distinct cell mechanical properties between diseased and healthy leukocytes. The BCB system achieves higher sensitivity than flow cytometry in detecting blasts. For complete details on the use and execution of this protocol, please refer to Khoo et al. (2019). Elsevier 2022-07-20 /pmc/articles/PMC9307522/ /pubmed/35880120 http://dx.doi.org/10.1016/j.xpro.2022.101584 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Fu, Yatian
Zou, Shangjie
Khoo, Bee Luan
Label-free enrichment of human blast cells from whole blood for leukemia monitoring
title Label-free enrichment of human blast cells from whole blood for leukemia monitoring
title_full Label-free enrichment of human blast cells from whole blood for leukemia monitoring
title_fullStr Label-free enrichment of human blast cells from whole blood for leukemia monitoring
title_full_unstemmed Label-free enrichment of human blast cells from whole blood for leukemia monitoring
title_short Label-free enrichment of human blast cells from whole blood for leukemia monitoring
title_sort label-free enrichment of human blast cells from whole blood for leukemia monitoring
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307522/
https://www.ncbi.nlm.nih.gov/pubmed/35880120
http://dx.doi.org/10.1016/j.xpro.2022.101584
work_keys_str_mv AT fuyatian labelfreeenrichmentofhumanblastcellsfromwholebloodforleukemiamonitoring
AT zoushangjie labelfreeenrichmentofhumanblastcellsfromwholebloodforleukemiamonitoring
AT khoobeeluan labelfreeenrichmentofhumanblastcellsfromwholebloodforleukemiamonitoring